نتائج البحث

1

Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: A phase II multicenter study

المساهمون: Vitolo, U, Chiappella, A, Angelucci, E, Rossi, G, Liberati, A, Cabras, M, Botto, B, Ciccone, G, Gaidano, G, Falchi, L, Freilone, R, Novero, D, Orsucci, L, Pavone, V, Pogliani, E, Rota Scalabrini, D, Salvi, F, Tonso, A, Tucci, A, Levis, A

مصطلحات موضوعية: Oncology, Male, Adult, dose-dense chemotherapy, medicine.medical_specialty, Time Factors, autologous stem cell transplantation, Dose-dense chemotherapy, Adolescent, Time Factor, diffuse large B-cell lymphoma, Transplantation, Autologous, Disease-Free Survival, Antibodies, Monoclonal, Murine-Derived, rituximab, Autologous stem-cell transplantation, International Prognostic Index, immune system diseases, Chemoimmunotherapy, MED/15 - MALATTIE DEL SANGUE, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Survival rate, Antineoplastic Combined Chemotherapy Protocol, business.industry, poor prognosis, high-dose chemotherapy, Antibodies, Monoclonal, Hematology, Middle Aged, medicine.disease, Surgery, Transplantation, Survival Rate, Transplantation, Autologou, Original Article, Rituximab, Female, Lymphoma, Large B-Cell, Diffuse, business, Diffuse large B-cell lymphoma, medicine.drug, Human, Stem Cell Transplantation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b604a8ed4dc5d73d04d27b4ec17d03caTest
http://hdl.handle.net/10281/20853Test

2

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: Final results of FIL HD0801 trial

المساهمون: Ricardi, U., Levis, M., Evangelista, A., Gioia, D. M., Sacchetti, G. M., Gotti, M., Re, A., Buglione, M., Pavone, V., Nardella, A., Nassi, L., Zanni, M., Franzone, P., Frezza, G. P., Pulsoni, A., Grapulin, L., Santoro, A., Rigacci, L., Simontacchi, G., Tani, M., Zaja, F., Abruzzese, E., Botto, B., Zilioli, V. R., Rota-Scalabrini, D., Freilone, R., Ciccone, G., Filippi, A. R., Zinzani, P. L., Ricardi U., Levis M., Evangelista A., Gioia D.M., Sacchetti G.M., Gotti M., Re A., Buglione M., Pavone V., Nardella A., Nassi L., Zanni M., Franzone P., Frezza G.P., Pulsoni A., Grapulin L., Santoro A., Rigacci L., Simontacchi G., Tani M., Zaja F., Abruzzese E., Botto B., Zilioli V.R., Rota-Scalabrini D., Freilone R., Ciccone G., Filippi A.R., Zinzani P.L.

المصدر: Blood Advances

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9b7535486b60d3f8dc20b8160c1abb9Test
https://hdl.handle.net/11368/3005933Test

3

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

المؤلفون: Antonella Anastasia, Pier Luigi Zinzani, Francesco Zaja, Simonetta Viviani, Stefano Luminari, Cinzia Pellegrini, Lisa Argnani, Barbara Botto, Armando Santoro, Paolo Corradini, Umberto Vitolo, Michele Spina, Alessandro Massimo Gianni, Enrico Derenzini, Ercole Brusamolino

المساهمون: Zinzani, Pl, Viviani, S, Anastasia, A, Vitolo, U, Luminari, S, Zaja, Francesco, Corradini, P, Spina, M, Brusamolino, E, Gianni, Am, Santoro, A, Botto, B, Derenzini, E, Pellegrini, C, Argnani, L., Zinzani PL, Viviani S, Anastasia A, Vitolo U, Luminari S, Zaja F, Corradini P, Spina M, Brusamolino E, Gianni AM, Santoro A, Botto B, Derenzini E, Pellegrini C, Argnani L

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3824c3f840b2ea02e72efdaabb01d7b7Test
https://hdl.handle.net/11368/2953688Test

4

First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi

المؤلفون: Umberto Vitolo, Vittorio Stefoni, Pier Luigi Zinzani, Alessandro Broccoli, Paolo Corradini, Stefano Fanti, Fondazione Italiana Linfomi Onlus, Alessandro Re, Antonello Pinto, Lisa Argnani, Barbara Botto

المساهمون: Broccoli, A, Argnani, L, Botto, B, Corradini, P, Pinto, A, Re, A, Vitolo, U, Fanti, S, Stefoni, V, Zinzani, P L, Fondazione Italiana Linfomi ONLUS

المصدر: Blood Cancer Journal, Vol 9, Iss 12, Pp 1-8 (2019)
Blood Cancer Journal

مصطلحات موضوعية: Bendamustine, Oncology, Adult, Male, medicine.medical_specialty, Phases of clinical research, Salvage therapy, Neutropenia, lcsh:RC254-282, Article, Young Adult, Autologous stem-cell transplantation, Refractory, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Bendamustine Hydrochloride, Humans, Brentuximab vedotin, Aged, Brentuximab Vedotin, Salvage Therapy, business.industry, Hematology, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Combined Modality Therapy, Hodgkin Disease, Magnetic Resonance Imaging, Clinical trial design, Regimen, Treatment Outcome, Female, Neoplasm Grading, bendamustine, brentuximab, vedotin, Hodgkin lymphoma, business, Tomography, X-Ray Computed, Haematological diseases, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::102ab5c7248a6568010361180f358463Test
http://link.springer.com/article/10.1038/s41408-019-0265-xTest

5

FDG–PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study

المؤلفون: Marilena Bellò, F. Morschhauser, Damien Huglo, Ivan Santi, Stefano Fanti, Enrico Derenzini, Egesta Lopci, Giordano Savelli, Barbara Botto, Francesco Bertagna, Pier Luigi Zinzani, Cristina Fonti

المساهمون: Lopci E, Santi I, Derenzini E, Fonti C, Savelli G, Bertagna F, Bellò M, Botto B, Huglo D, Morschhauser F, Zinzani P, Fanti S.

المصدر: Annals of Oncology. 21:1877-1883

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a79c5ec0913e5ffe3b916cd1d670e78fTest
https://doi.org/10.1093/annonc/mdq024Test

6

Phase II Trial of Short-Course R-Chop Followed by 90Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients

المساهمون: Zinzani P.L., Rossi G., Franceschetti S., Botto B., Di Rocco A., Cabras M.G., Petti M.C., Stefoni V., Broccoli A., Fanti S., Pellegrini C., Montini G.C., Gandolfi L., Derenzini E., Argnani L., Fina M., Tucci A., Bottelli C., Pileri S., Baccarani M.

المصدر: Clinical Cancer Research. 16:3998-4004

مصطلحات موضوعية: Murine-Derived, Male, Cancer Research, medicine.medical_specialty, Lymphoma, medicine.medical_treatment, Ibritumomab tiuxetan, Kaplan-Meier Estimate, CHOP, Neutropenia, Gastroenterology, Antibodies, Disease-Free Survival, Antibodies, Monoclonal, Murine-Derived, Risk Factors, Internal medicine, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Large B-Cell, medicine, Humans, Cyclophosphamide, Aged, Neoplasm Staging, Aged, 80 and over, Chemotherapy, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, Diffuse, Surgery, Doxorubicin, Female, Lymphoma, Large B-Cell, Diffuse, Prednisone, Rituximab, Treatment Outcome, Vincristine, Regimen, Oncology, Radioimmunotherapy, business, Diffuse large B-cell lymphoma, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa53d181e5980b5a58078f4115433e8Test
https://doi.org/10.1158/1078-0432.ccr-10-0162Test

7

Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi

المساهمون: Vitolo, U, Ladetto, M, Boccomini, C, Baldini, L, De Angelis, F, Tucci, A, Botto, B, Chiappella, A, Chiarenza, A, Pinto, A, De Renzo, A, Zaja, Francesco, Castellino, C, Bari, A, Alvarez De Celis, I, Evangelista, A, Parvis, G, Gamba, E, Lobetti Bodoni, C, Ciccone, G, Rossi, G.

المصدر: Scopus-Elsevier

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e64eacec87697ebcd416e2b86ed2278Test
http://hdl.handle.net/11390/1047395Test

8

Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination

المساهمون: Benevolo, G, Stacchini, A, Spina, M, Ferreri, A, Arras, M, Bellio, L, Botto, B, Bulian, P, Cantonetti, M, Depaoli, L, Di Renzo, N, Di Rocco, A, Evangelista, A, Franceschetti, S, Godio, L, Mannelli, F, Pavone, V, Pioltelli, P, Vitolo, U, Pogliani, E

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Pathology, Cytodiagnosis, Immunology, Population, Biochemistry, Gastroenterology, Immunophenotyping, Risk Factors, Internal medicine, Multicenter trial, medicine, Meningeal Neoplasms, Humans, Cumulative incidence, Prospective Studies, Prospective cohort study, education, MED/05 - PATOLOGIA CLINICA, Neoplasm Staging, education.field_of_study, business.industry, Incidence, Lymphoma, Non-Hodgkin, Hazard ratio, aggressive Lymphoma, cerebrospinal fluid, flow cytometry, CNS prophylaxis, Cell Biology, Hematology, Middle Aged, medicine.disease, Flow Cytometry, Prognosis, Combined Modality Therapy, Lymphoma, Italy, Female, Neoplasm Recurrence, Local, business, Diffuse large B-cell lymphoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d367d8dbac47db1b08f4eaa50d939b5Test
http://hdl.handle.net/10281/37240Test

تنقيح النتائج